|
|
|
市場調查報告書
眼科最新動向：眼疾・視力矯正治療市場（第2版）
Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision, 2nd Ediiton
|
眼科最新動向：眼疾・視力矯正治療市場（第2版） 是由出版商Kalorama Information在2009年07月所出版的。
這份英文市場調查報告書包含200 pages 價格從美金3500起跳。
本報告書內容包括：美國及其他主要各國眼科市場的綜合分析、現況及2013年之前的預測、視力矯正及眼疾個別分類的治療技術動向等。內容綱要摘記如下：
第1章 實施概要
第2章 介紹及概要
第3章 眼科的問題及動向
- 概要
- 變化的阻力
- 新的技術革命
- 屈光矯正
- 主要眼疾
- 法規限制
- 智慧財產、資產管理
第4章 視力障礙矯正
第5章 眼疾
- 概要
- 白内障
- 青光眼
- 加齡性黄斑病性
- 水晶體網膜症
第6章 屈光矯正：產品及技術
- 概要
- 競爭治療技術
- 競爭產品、技術、應用、市場動向
第7章 主要眼疾：產品及技術
- 概要
- 競爭技術摘要
- 白内障
- 青光眼
- 加齡性黄斑病性
- 水晶體網膜症
第8章 市場摘要
第9章 屈光矯正市場分析及預測
- 背景
- 市場及競爭分析
- 屈光矯正市場：設備、用品、工具
- 屈光矯正市場：服務
第10章 主要眼疾市場分析及預測
第11章 企業介紹
附錄
Abstract
The information represented in this report is a comprehensive analysis of the
eye care market globally with a special focus on the United States and
selected international sectors. The year ending December 31, 2008 was used as
the base year with forecasts to the year 2013. Market statistics are given in
U.S. dollars and in units [where appropriate]. Basis for the market analysis
consists of key data, statistics; references, and information from a large
data base of primary and secondary research sources documented in the report
consisting of interviews, professional meetings; conferences; presentations;
journals; consumer media [radio, TV, magazines, newspapers]; and Internet
content involving more than 40,000 sources. Data were collected for global
populations and medical providers who represent the key influences in the eye
care market.
The market analysis is comprised of two major sectors:
- refractive vision correction [addressing myopia, hyperopia, presbyopia,
and astigmatism
- and major eye diseases [addressing cataracts, glaucoma, AMD, retinal
disorders
Within the primary sectors the analysis includes the top RVC treatment
modalities [traditional and advanced laser systems; RVC lens implants, and
alternative surgical implants] and surgical intervention for each of the major
diseases [retinal laser surgery, photo dynamic therapy, pneumatic
thermoplasticy, capsulectomy, and trabeculectomy]. Competitive market shares
are given for the key manufacturers of RVC treatment methodologies and for
major devices and ophthalmic therapeutics employed in the management of eye
diseases.
New technologies and treatment modalities for both visual acuity and major eye
diseases may dramatically change the composition and competitive dynamics of
the ophthalmology market. This report explores these dynamics and discoveries
along with their profound impact on clinical eye care and the competitive
positions of the market supplier. Also examined are traditional [conventional]
approaches, the role of medical skills and techniques developed and cultivated
over past years, and the importance of supporting increasingly global demand
to correct vision deficiencies.
Other competitive technologies presented herein under the heading of
refractive vision correction [RVC] include:
- Integrated [diagnostic] laser surgery
- RF conductive keratoplasty
- Earlier versions of corrective laser systems.
This segment also includes RVC breakthrough technologies such as
- Imaging topography
- Accommodating implants
- Special vision lens
- Vision restoration systems and
- Other evolving technologies
Vision abnormalities [restoration of impaired vision] presented and
investigated are confined to following four primary conditions:
- Myopia [nearsightedness] - leading eye disorder affecting all age groups
- Hyperopia [farsightedness] - second leading eye disorder affecting all age
groups
- Presbyopia [near focus abnormality] - phenomenon of aging, mostly 40 +
year olds
- Astigmatism [cornea irregularities, eye globe distortion] - affects all
age groups
The range of therapeutic modalities mentioned above offers multiple options in
treating one or more of the four primary diseases. While some modalities like
ophthalmic pharmaceuticals are used to treat one disease, other medical
devices like lasers and implants [Refocus Group' s PresView SRP - Scleral Lens
Spacers] are more flexible and used in multiple applications for
disease-specific procedures.
The market described herein is also positioning itself to resolve its most
compelling problems effecting older populations - the alarming increase in
loss of vision worldwide resulting from diseases, aging, and declining health
conditions. The race is underway to develop and exploit cutting-edge
technologies [diagnostics, imaging, therapeutics, devices] that will address
the growing threat of deteriorating vision and blindness caused by the most
serious eye diseases, including:
- Cataracts - surgery & replacement intra ocular lens [IOL] and
accommodating lens,
- Glaucoma/Ocular Hypertension - chronic opened-angle and acute closedangle
" Age-Related Macular Degeneration [AMD] - both wet and dry, and
- Retinal Disorders - diabetic retinopathy, diabetic edema, detached retina.
While technological innovations continue to play a crucial role in slowing [or
stopping] the progress of vision loss through laser surgery and other medical
and therapeutic intervention, early diagnosis of these diseases and knowledge
of available treatment options is equally crucial to prevent the progression
and further deterioration of vision. However, the availability of
technologies, medical disciplines, and skills to take advantage of the gains
made in managing eye diseases has yet to realize its full competitive and
market potential. And many players entering this field will find this report a
useful resource.
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Overview
- Objectives, Scope, and Methodology
- Summary Of Findings
- Overview of Current Market Dynamics
- Market Analysis and Forecasts
CHAPTER TWO: INTRODUCTION AND OVERVIEW
- Overview
- History in Treating Eye Diseases
- World Demographics
- Population by Gender
- Aging Population
- Staggering World Facts
CHAPTER THREE: ISSUES AND TRENDS IN THE OPHTHALMOLOGY INDUSTRY
- Overview
- Resistance to Change
- The New Technological Revolution
- Refractive Vision Correction [RVC]
- Patient Reported Outcomes for Laser in situ Keratomileusis (LASIK)
Surgery
- World Economy and Refractive Surgery
- Typical Refractive Demographic 2009
- Major Eye Diseases
- Regulation
- Government' s Role as Overseer
- Government Mandate: Safety & Effectiveness
- Developed & Underdeveloped Countries Off-Label Use Ophthalmologists vs
Optometrists Business Challenges in a Regulated Environment
- Intellectual Property, Asset Ownership
- International Trade [Export/Import] Governance in a Publicly-Owned
Company
CHAPTER FOUR: RESTORATION OF IMPAIRED VISION
- Treatment of Leading Vision Disorders
- The Global Opportunity
- Conventional Eye Glasses and Contact Lens
- Conventional Eye Glasses
- Traditional Contact Lenses
- Other Corrective Modalities
- LASIK/Laser Surgery Intervention
- RF Conductive Keratoplasty [RFK]
- Correctable Vision Implants - Spacers/Inserts
- Other Investigational Treatments for Presbyopia
- Temporary Correctable Vision Lenses
- Lens Implants - Phakic & Implantable Lens Implants [ICL]
- Challenges & Threats in the Global Marketplace
CHAPTER FIVE: DISEASES AFFECTING THE EYE
- Overview
- Cataracts
- Glaucoma
- Macular Degeneration
- Vitreoretinal Disorders
- Diabetic Retinopathy [DR]
- Diabetic Macular Edema [DME]
- Retinal Detachment [RD]
CHAPTER SIX: REFRACTIVE VISION CORRECTION: PRODUCTS AND TECHNOLOGIES
- Overview
- Competing Treatment Technologies
- Competitive Products, Technology, Applications & Market Status
CHAPTER SEVEN: MAJOR EYE DISEASES: PRODUCTS AND TECHNOLOGIES
- Overview
- Summary of Competing Technologies
- Cataract
- Glaucoma
- Age-Related Macular Degeneration
- Vitreoretinal Conditions
CHAPTER EIGHT: MARKET SUMMARY
- Description of the Market
- Eye Care Challenges
- The Aging Process and Complications of Chronic Conditions
- Technology Overcomes Obsolete Methodologies
- Older Treatment Modalities
- Advanced Treatment Modalities
- Pressures Influencing Structural Changes
- Market Influences
CHAPTER NINE: REFRACTIVE VISION CORRECTION MARKET ANALYSIS & FORECAST
- Background
- Eye Glasses & Contact Lenses
- Prevention & Wellness
- Laser Surgery & Other Corrective Alternatives
- Market and Competitive Analysis
- Refractive Vision Correction Markets: Equipment, Supplies, and Devices
- Refractive Vision Correction Markets: Services
CHAPTER TEN: MAJOR EYE DISEASES: MARKET ANALYSIS & FORECAST
- Market Challenges
- Market and Competitive Analysis
- Eye Disease Markets: Equipment, Supplies, and Devices
- Markets by Eye Disease
- Cataracts - Surgical Intervention and Devices
- Glaucoma Treatment and Management
- Vitreoretinal - Conventional & Advanced Treatments
- Other Treatments - Allergy, Dry Eye, Infection, Inflammation
- Eye Disease Markets: Services
CHAPTER ELEVEN:COMPANY PROFILES
- Overview
- Abbott Medical Optics, Inc
- Products/Technology/Intellectual Property
- Financial Performance and Segment Analysis
- Alcon, Inc
- Products/Technology/Intellectual Property
- Focus & Future Strategy
- Allergan, Inc
- Business Overview
- Products and Strategy
- Heidelberg Engineering, Inc
- Business Overview
- Products and Technology
- Nidek Co. Ltd.
- Business Overview
- Products/Technology/Intellectual Property
- STAAR Surgical Company
- Business Overview
- Products/Technology/Intellectual Property
- Strategy
- Novartis
- Business Overview
- Products & Strategy
- Carl Zeiss Meditec AG
- Products, Strategy and Focus
APPENDIX A: GLOSSARY AND ABBREVIATIONS
APPENDIX B: PROFESSIONAL/SCIENTIFIC SOURCES
APPENDIX C: NEWS/RESEARCH SOURCES
APPENDIX D: U.S. REGULATORY AUTHORITIES AND STATUTES
APPENDIX E: INTERNATIONAL REGULATORY AUTHORITIES AND STATUTES
APPENDIX F: ASSOCIATIONS, SOCIETIES, FOUNDATIONS FOR EYE HEALTH
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Table 1-1: Ophthalmology Market: Product and Service Revenues [combined
eye diseases and refractive], 2006-2013
CHAPTER TWO: INTRODUCTION AND OVERVIEW
- Table 2-1: Estimated and Projected World Population by Selected
Geographical Region, 2008-2050 (in millions)
- Figure 2-1: Estimated and Projected World Population by Selected
Geographical Region, 2008-2050
- Table 2-2: Number and Percent Population by Sex and Region, 2008
- Table 2-3: Estimated World Population by Age and Geographical Region, 2008
(in millions)
- Figure 2-2: Estimated World Population by Age and Geographical Region, 2008
- Figure 2-3: Estimated World Population by Age Group
CHAPTER FOUR: RESTORATION OF IMPAIRED VISION
- Table 4-1: Primary Visual Acuity Conditions and Refractive Vision
Correction Treatment Options
CHAPTER FIVE: DISEASES AFFECTING THE EYE
- Table 5-1: Diagnostics & Treatment Modalities for the Management of Eye
Diseases
CHAPTER SIX: REFRACTIVE VISION CORRECTION: PRODUCTS AND TECHNOLOGIES
- Table 6-1: Refractive Vision Correction Competitive Products, Technology,
Application, Market Status
CHAPTER SEVEN: MAJOR EYE DISEASES: PRODUCTS AND TECHNOLOGIES
- Table 7-1: Major Eye Diseases Competitors, Competitive Products,
Technology, Application, and Market Status
CHAPTER EIGHT: MARKET SUMMARY
- Table 8-1: Ophthalmology Market: Product and Service Revenues [combined
eye diseases and refractive], 2006-2013
CHAPTER NINE: REFRACTIVE VISION CORRECTION MARKET ANALYSIS & FORECAST
- Table 9-1: Refractive Vision Correction Market: Equipment and Product
Revenues and Annual Growth by Geography (U.S. and Non-U.S.), 2006-2013
- Table 9-2: Refractive Vision Correction Market: Equipment and Product
Supplier Revenues and Market Share by Geography, 2008
- Table 9-3: Refractive Vision Correction Market: Service Revenues and
Annual Growth by Geography (U.S. and Non-U.S.), 2006-2013
- Table 9-4: Refractive Vision Correction Market: Service Revenues and
Market Share by Provider Type and Geography, 2008
- Table 9-5: Refractive Vision Correction Market: Service Revenues and
Market Share by Geography (U.S. vs Non-U.S.) and Condition Treated (Myopia,
Hyperopia, Presbyopia, Astigmatism), 2008
CHAPTER TEN: MAJOR EYE DISEASES: MARKET ANALYSIS & FORECAST
- Table 10-1: Eye Disease Market: Product Revenues and Annual Growth by
Geography (U.S. and Non-U.S.), 2006-2013
- Table 10-2: Eye Disease Market: Supplier Revenues and Market Share by
Geography, 2008
- Table 10-3: Major Eye Disease Market: Supplier Revenues and Market Share
by Condition (Cataract, Glaucoma, Vitreoretinal, Others), 2008
- Table 10-4: Eye Disease Treatment Market: Service Revenues and Annual
Growth by Geography (U.S. and Non-U.S.), 2006-2013
- Table 10-5: Eye Disease Treatment Market: Service Revenues and Market
Share by Provider Type and Geography, 2008
- Table 10-6: Eye Disease Treatment Market: Provider Service Revenues and
Market Share by Geography (U.S. vs Non-U.S.) and Condition Treated (Cataract,
Glaucoma, Vitreoretinal, Other), 2008
|
 |
